The Bank of New York Mellon Corporation

Alcentra to Take on Collateralised Loan Business of Rabobank

Published in Health Business Week, August 14th, 2009

Alcentra*, a specialist asset manager focused on the sub-investment grade debt markets and part of BNY Mellon Asset Management, has announced that Alcentra NY, LLC, has entered into a definitive agreement to take on the Collateralized Loan Obligation (CLO) business of Rabobank Nederland, New York branch. The business consists of four cash flow CLOs and two Synthetic CDOs, issued under the Prospero, Veritas and Archstone names.

The transaction, which closed on 30 July 2009, will add approximately $1.53bn to Alcentra's AUM, taking its global total to more than $18bn across 41 separate funds. Following the transaction, Ron Grobeck (Portfolio Manager) and two analysts will...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2009-08-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry